{"product_id":"communications-fda-ani-pharmaceuticals-anda-208607-methylphenidate-er-tablets-feb-apr-2019","title":"Communications – FDA \u0026 ANI Pharmaceuticals (ANDA 208607, Methylphenidate ER Tablets, Feb–Apr 2019)","description":"\u003cb\u003eRequest Contents:\u003c\/b\u003e Copies of all written communications between FDA and ANI Pharmaceuticals, Inc. from February 2, 2019, to April 24, 2019, related to ANDA Application No. 208607 and\/or ANI’s generic version of Methylphenidate Hydrochloride Extended-Release (ER) tablets (18 mg, 27 mg, 36 mg, 54 mg).","brand":"FDA","offers":[{"title":"Default Title","offer_id":50791082786980,"sku":"FDAFT250","price":89.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/foiadocs.com\/products\/communications-fda-ani-pharmaceuticals-anda-208607-methylphenidate-er-tablets-feb-apr-2019","provider":"FOIA Document Source","version":"1.0","type":"link"}